Literature DB >> 34287049

Targeted Long-Read Sequencing Reveals Comprehensive Architecture, Burden, and Transcriptional Signatures from Hepatitis B Virus-Associated Integrations and Translocations in Hepatocellular Carcinoma Cell Lines.

Ricardo Ramirez1, Nicholas van Buuren1, Lindsay Gamelin1, Cameron Soulette1, Lindsey May1, Dong Han1, Mei Yu1, Regina Choy1, Guofeng Cheng1, Neeru Bhardwaj1, Joy Chiu1, Robert C Muench1, William E Delaney1, Hongmei Mo1, Becket Feierbach1, Li Li1.   

Abstract

Hepatitis B virus (HBV) can integrate into the chromosomes of infected hepatocytes, creating potentially oncogenic lesions that can lead to hepatocellular carcinoma (HCC). However, our current understanding of integrated HBV DNA architecture, burden, and transcriptional activity is incomplete due to technical limitations. A combination of genomics approaches was used to describe HBV integrations and corresponding transcriptional signatures in three HCC cell lines: huH-1, PLC/PRF/5, and Hep3B. To generate high-coverage, long-read sequencing data, a custom panel of HBV-targeting biotinylated oligonucleotide probes was designed. Targeted long-read DNA sequencing captured entire HBV integration events within individual reads, revealing that integrations may include deletions and inversions of viral sequences. Surprisingly, all three HCC cell lines contain integrations that are associated with host chromosomal translocations. In addition, targeted long-read RNA sequencing allowed for the assignment of transcriptional activity to specific integrations and resolved the contribution of overlapping HBV transcripts. HBV transcripts chimeric with host sequences were resolved in their entirety and often included >1,000 bp of host sequence. This study provides the first comprehensive description of HBV integrations and associated transcriptional activity in three commonly utilized HCC-derived cell lines. The application of novel methods sheds new light on the complexity of these integrations, including HBV bidirectional transcription, nested transcripts, silent integrations, and host genomic rearrangements. The observation of multiple HBV-associated chromosomal translocations gives rise to the hypothesis that HBV is a driver of genetic instability and provides a potential new mechanism for HCC development. IMPORTANCE HCC-derived cell lines have served as practical models to study HBV biology for decades. These cell lines harbor multiple HBV integrations and express only HBV surface antigen (HBsAg). To date, an accurate description of the integration burden, architecture, and transcriptional profile of these cell lines has been limited due to technical constraints. We have developed a targeted long-read sequencing assay that reveals the entire architecture of integrations in these cell lines. In addition, we identified five chromosomal translocations with integrated HBV DNA at the interchromosomal junctions. Incorporation of long-read transcriptome sequencing (RNA-Seq) data indicated that many integrations and translocations were transcriptionally silent. The observation of multiple HBV-associated translocations has strong implications regarding the potential mechanisms for the development of HBV-associated HCC.

Entities:  

Keywords:  HBV; HCC; chromosomal translocation; viral integration

Mesh:

Substances:

Year:  2021        PMID: 34287049      PMCID: PMC8428387          DOI: 10.1128/JVI.00299-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Diversity of hepatitis B virus X gene-related transcripts in hepatocellular carcinoma: a novel polyadenylation site on viral DNA.

Authors:  C Hilger; I Velhagen; H Zentgraf; C H Schröder
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients.

Authors:  Zhaoshi Jiang; Suchit Jhunjhunwala; Jinfeng Liu; Peter M Haverty; Michael I Kennemer; Yinghui Guan; William Lee; Paolo Carnevali; Jeremy Stinson; Stephanie Johnson; Jingyu Diao; Stacy Yeung; Adrian Jubb; Weilan Ye; Thomas D Wu; Sharookh B Kapadia; Frederic J de Sauvage; Robert C Gentleman; Howard M Stern; Somasekar Seshagiri; Krishna P Pant; Zora Modrusan; Dennis G Ballinger; Zemin Zhang
Journal:  Genome Res       Date:  2012-01-20       Impact factor: 9.043

3.  HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.

Authors:  William S Mason; Upkar S Gill; Samuel Litwin; Yan Zhou; Suraj Peri; Oltin Pop; Michelle L W Hong; Sandhia Naik; Alberto Quaglia; Antonio Bertoletti; Patrick T F Kennedy
Journal:  Gastroenterology       Date:  2016-07-22       Impact factor: 22.682

4.  Residual integrated viral DNA after hepadnavirus clearance by nucleoside analog therapy.

Authors:  Jesse Summers; William S Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-29       Impact factor: 11.205

Review 5.  HBV DNA Integration: Molecular Mechanisms and Clinical Implications.

Authors:  Thomas Tu; Magdalena A Budzinska; Nicholas A Shackel; Stephan Urban
Journal:  Viruses       Date:  2017-04-10       Impact factor: 5.048

6.  TSD: A Computational Tool To Study the Complex Structural Variants Using PacBio Targeted Sequencing Data.

Authors:  Guofeng Meng; Ying Tan; Yue Fan; Yan Wang; Guang Yang; Gregory Fanning; Yang Qiu
Journal:  G3 (Bethesda)       Date:  2019-05-07       Impact factor: 3.154

7.  Genomic modeling of hepatitis B virus integration frequency in the human genome.

Authors:  Ondrej Podlaha; George Wu; Bryan Downie; Raghuraman Ramamurthy; Anuj Gaggar; Mani Subramanian; Zhishen Ye; Zhaoshi Jiang
Journal:  PLoS One       Date:  2019-07-29       Impact factor: 3.240

8.  Spatiotemporal Analysis of Hepatitis B Virus X Protein in Primary Human Hepatocytes.

Authors:  Simon P Fletcher; Rudolf K Beran; Dmytro Kornyeyev; Dhivya Ramakrishnan; Christian Voitenleitner; Christine M Livingston; Weimei Xing; Magdeleine Hung; Hyock Joo Kwon
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

9.  Stronger enhancer II/core promoter activities of hepatitis B virus isolates of B2 subgenotype than those of C2 subgenotype.

Authors:  Yanli Qin; Xueshi Zhou; Haodi Jia; Chaoyang Chen; Weifeng Zhao; Jiming Zhang; Shuping Tong
Journal:  Sci Rep       Date:  2016-07-27       Impact factor: 4.379

10.  Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers.

Authors:  Mayuko Furuta; Hiroko Tanaka; Yuichi Shiraishi; Takuro Unida; Michio Imamura; Akihiro Fujimoto; Masahi Fujita; Aya Sasaki-Oku; Kazuhiro Maejima; Kaoru Nakano; Yoshiiku Kawakami; Koji Arihiro; Hiroshi Aikata; Masaki Ueno; Shinya Hayami; Shun-Ichi Ariizumi; Masakazu Yamamoto; Kunihito Gotoh; Hideki Ohdan; Hiroki Yamaue; Satoru Miyano; Kazuaki Chayama; Hidewaki Nakagawa
Journal:  Oncotarget       Date:  2018-05-18
View more
  10 in total

1.  Conserved Lysine Residues of Hepatitis B Virus Core Protein Are Not Required for Covalently Closed Circular DNA Formation.

Authors:  Xupeng Hong; Jianming Hu
Journal:  J Virol       Date:  2022-07-18       Impact factor: 6.549

2.  Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo.

Authors:  Cassandra L Gorsuch; Paige Nemec; Mei Yu; Simin Xu; Dong Han; Jeff Smith; Janel Lape; Nicholas van Buuren; Ricardo Ramirez; Robert C Muench; Meghan M Holdorf; Becket Feierbach; Greg Falls; Jason Holt; Wendy Shoop; Emma Sevigny; Forrest Karriker; Robert V Brown; Amod Joshi; Tyler Goodwin; Ying K Tam; Paulo J C Lin; Sean C Semple; Neil Leatherbury; William E Delaney Iv; Derek Jantz; Amy Rhoden Smith
Journal:  Mol Ther       Date:  2022-05-16       Impact factor: 12.910

3.  Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease.

Authors:  Andrea Magri; James M Harris; Valentina D'Arienzo; Rosalba Minisini; Frank Jühling; Peter A C Wing; Rachele Rapetti; Monica Leutner; Barbara Testoni; Thomas F Baumert; Fabien Zoulim; Peter Balfe; Mario Pirisi; Jane A McKeating
Journal:  Viruses       Date:  2022-05-17       Impact factor: 5.818

4.  The third international hackathon for applying insights into large-scale genomic composition to use cases in a wide range of organisms.

Authors:  Kimberly Walker; Divya Kalra; Rebecca Lowdon; Guangyi Chen; David Molik; Daniela C Soto; Fawaz Dabbaghie; Ahmad Al Khleifat; Medhat Mahmoud; Luis F Paulin; Muhammad Sohail Raza; Susanne P Pfeifer; Daniel Paiva Agustinho; Elbay Aliyev; Pavel Avdeyev; Enrico R Barrozo; Sairam Behera; Kimberley Billingsley; Li Chuin Chong; Deepak Choubey; Wouter De Coster; Yilei Fu; Alejandro R Gener; Timothy Hefferon; David Morgan Henke; Wolfram Höps; Anastasia Illarionova; Michael D Jochum; Maria Jose; Rupesh K Kesharwani; Sree Rohit Raj Kolora; Jędrzej Kubica; Priya Lakra; Damaris Lattimer; Chia-Sin Liew; Bai-Wei Lo; Chunhsuan Lo; Anneri Lötter; Sina Majidian; Suresh Kumar Mendem; Rajarshi Mondal; Hiroko Ohmiya; Nasrin Parvin; Carolina Peralta; Chi-Lam Poon; Ramanandan Prabhakaran; Marie Saitou; Aditi Sammi; Philippe Sanio; Nicolae Sapoval; Najeeb Syed; Todd Treangen; Gaojianyong Wang; Tiancheng Xu; Jianzhi Yang; Shangzhe Zhang; Weiyu Zhou; Fritz J Sedlazeck; Ben Busby
Journal:  F1000Res       Date:  2022-05-16

5.  Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B.

Authors:  Nicholas van Buuren; Ricardo Ramirez; Cameron Soulette; Vithika Suri; Dong Han; Lindsey May; Scott Turner; P C Parvangada; Ross Martin; Henry L Y Chan; Patrick Marcellin; Maria Buti; Nam Bui; Neeru Bhardwaj; Anuj Gaggar; Li Li; Hongmei Mo; Becket Feierbach
Journal:  JHEP Rep       Date:  2022-02-12

Review 6.  Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure.

Authors:  Romina Salpini; Stefano D'Anna; Livia Benedetti; Lorenzo Piermatteo; Upkar Gill; Valentina Svicher; Patrick T F Kennedy
Journal:  Front Microbiol       Date:  2022-09-02       Impact factor: 6.064

Review 7.  Advances in multi-omics research on viral hepatitis.

Authors:  Ze Xiang; Jiayuan Li; Di Lu; Xuyong Wei; Xiao Xu
Journal:  Front Microbiol       Date:  2022-09-02       Impact factor: 6.064

8.  Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment.

Authors:  Tanner Grudda; Hyon S Hwang; Maraake Taddese; Jeffrey Quinn; Mark S Sulkowski; Richard K Sterling; Ashwin Balagopal; Chloe L Thio
Journal:  J Clin Invest       Date:  2022-09-15       Impact factor: 19.456

9.  Secreted hepatitis B virus splice variants differ by HBV genotype and across phases of chronic hepatitis B infection.

Authors:  Olivia Maslac; Josef Wagner; Vitina Sozzi; Hugh Mason; Jenny Svarovskaia; Susanna Tan; Anuj Gaggar; Stephen Locarnini; Lilly Yuen; Margaret Littlejohn; Peter A Revill
Journal:  J Viral Hepat       Date:  2022-05-28       Impact factor: 3.517

10.  Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection.

Authors:  Nicholas van Buuren; Ricardo Ramirez; Scott Turner; Diana Chen; Vithika Suri; Abhishek Aggarwal; Christina Moon; Sam Kim; Dmytro Kornyeyev; Nam Bui; Neeru Bhardwaj; Henry Ly Chan; Patrick Marcellin; Maria Buti; Jeffrey Wallin; Anuj Gaggar; Simon P Fletcher; Lauri Diehl; Li Li; Hongmei Mo; Becket Feierbach
Journal:  JHEP Rep       Date:  2021-10-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.